{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:27:36Z","timestamp":1793618856469,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ebiom.2026.106526","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:31:12Z","timestamp":1792585872000},"page":"106526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early treatment with tecovirimat against mpox disease in cynomolgus macaques"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5298-0288","authenticated-orcid":false,"given":"Annika","family":"R\u00f6ssler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malika","family":"Aid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Ayala-Bernot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5861-7067","authenticated-orcid":false,"given":"Andrew T.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas W.","family":"Grosenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace","family":"Lovejoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1103-9608","authenticated-orcid":false,"given":"Hanne","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis E.","family":"Hruby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5127-4659","authenticated-orcid":false,"given":"Dan H.","family":"Barouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2026.106526_bib1","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3390\/v2112409","article-title":"Development of ST-246\u00ae for treatment of poxvirus infections","volume":"2","author":"Jordan","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.ebiom.2026.106526_bib2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3201\/eid1307.061188","article-title":"Emergency use Authorization (EUA) to enable use of needed products in civilian and military emergencies, United States","volume":"13","author":"Nightingale","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106526_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2019.06.005","article-title":"The development and approval of tecoviromat (TPOXX(\u00ae)), the first antiviral against smallpox","volume":"168","author":"Merchlinsky","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ebiom.2026.106526_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013140","article-title":"Tecovirimat: a journey from discovery to mechanistic insights in poxvirus inhibition","volume":"21","author":"Li","year":"2025","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2026.106526_bib5","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2026.106526_bib6","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/jac\/dku545","article-title":"ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping","volume":"70","author":"Duraffour","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ebiom.2026.106526_bib7","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1128\/AAC.01689-09","article-title":"Safety and pharmacokinetics of the antiorthopoxvirus compound ST-246 following repeat oral dosing in healthy adult subjects","volume":"54","author":"Jordan","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2026.106526_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral tecovirimat for the treatment of smallpox","volume":"379","author":"Grosenbach","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106526_bib9","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1128\/AAC.00977-13","article-title":"Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox)","volume":"57","author":"Mucker","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2026.106526_bib10","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJMoa2506495","article-title":"Tecovirimat for the treatment of mpox","volume":"394","author":"Zucker","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106526_bib11","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/AAC.01596-08","article-title":"ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification","volume":"53","author":"Jordan","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2026.106526_bib12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/AAC.00879-06","article-title":"Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice","volume":"51","author":"Quenelle","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2026.106526_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2008.03.005","article-title":"Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model","volume":"79","author":"Nalca","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ebiom.2026.106526_bib14","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/infdis\/jiy326","article-title":"Effects of treatment delay on efficacy of tecovirimat following lethal aerosol monkeypox virus challenge in cynomolgus macaques","volume":"218","author":"Russo","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106526_bib15","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/AAC.00021-09","article-title":"Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246","volume":"53","author":"Huggins","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2026.106526_bib16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.vaccine.2019.10.049","article-title":"Co-administration of tecovirimat and ACAM2000\u2122 in non-human primates: effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge","volume":"38","author":"Russo","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2026.106526_bib17","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1128\/AAC.00904-12","article-title":"Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteers","volume":"56","author":"Chinsangaram","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2026.106526_bib18","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJMoa2412439","article-title":"Tecovirimat for clade I MPXV infection in the Democratic Republic of Congo","volume":"392","author":"Ali","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106526_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/v17121526","article-title":"Mpox: exploring epidemiology, disease outcomes, and preventative vaccination among people with HIV during the ongoing outbreaks","volume":"17","author":"Orkin","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.ebiom.2026.106526_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2332669","article-title":"Mpox virus Clade IIb infected Cynomolgus macaques via mimic natural infection routes closely resembled human mpox infection","volume":"13","author":"Li","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ebiom.2026.106526_bib21","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1016\/j.cell.2023.08.023","article-title":"Mpox infection protects against re-challenge in rhesus macaques","volume":"186","author":"Aid","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2026.106526_bib22","series-title":"Clinical signs and symptoms of monkeypox","year":"2026"},{"key":"10.1016\/j.ebiom.2026.106526_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adl4317","article-title":"Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques","volume":"16","author":"Jacob-Dolan","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2026.106526_bib24","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.4049\/jimmunol.1600066","article-title":"IL-10 enhances IgE-Mediated mast cell responses and is essential for the development of experimental food allergy in IL-10-Deficient mice","volume":"196","author":"Polukort","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2026.106526_bib25","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1128\/JVI.01931-10","article-title":"Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route","volume":"85","author":"Johnson","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2026.106526_bib26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries - April-June 2022","volume":"387","author":"Thornhill","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106526_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002249","article-title":"Early administration of tecovirimat shortens the time to mpox clearance in a model of human infection","volume":"21","author":"Nguyen","year":"2023","journal-title":"PLoS Biol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642600410X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642600410X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T10:51:16Z","timestamp":1793616676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642600410X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":27,"alternative-id":["S235239642600410X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106526","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early treatment with tecovirimat against mpox disease in cynomolgus macaques","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106526"}}